Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| Overall, we are pleased with our results for the quarter, which saw Organigram once again deliver positive adjusted EBITDA and improved adjusted gross margins |
| So, as I said, I think those factors will continue to drive margin improvements, as we get through the rest of the year |
| Our R&D capabilities are beginning to more rapidly translate to technical know-how that is expected to provide Organigram with competitive advantages for years to come, spanning from more robust plants to better consumer experiences backed by science and rigorous testing protocols |
| As has been the case historically, Organigram will continue to drive growth and shareholder value through an industry-leading focus on innovation and the integration of new technologies that provide sustainable competitive advantages for the company and differentiated experiences for consumers at home and abroad |
| And so this is a great opportunity for us and totally incremental |
| As Beena mentioned, we started off the quarter achieving positive adjusted EBITDA and positive cash flow from operations, demonstrating our investments in automation and our commitment to long-term efficiencies that are beginning to pay off |
| As we focus on driving domestic and international market share gains through continued innovation and expansion into vapes, refining our product and geographic mix and reaping the benefits from increased automation at our facilities, we expect our margins to demonstrate more stability in fiscal '24 compared to fiscal '23 |
| We also delivered positive adjusted EBITDA and cash flow from operations of $7.7 million |
| Organigram is now uniquely positioned to take advantage of these opportunities |
| Nice to see the gross margin improvement during the quarter along with some of the other achievements you had |
| Our facility's unique characteristics recently enhanced by most of our $29 million in efficiency driving CapEx projects completed last year present several other advantages |
| We don't have to reinvent the wheel and we're excited about these opportunities going forward |
| As this materializes, Organigram stands to cement itself as a long-term industry leader, owing to its strong balance sheet, increasing production efficiency, industry-leading R&D and reinvigorated focus on international expansion supported by Project Jupiter |
| Looking at our earnings for the quarter, which Greg will expand on shortly, we are pleased to deliver adjusted gross margins, which returned to our previously reported levels |
| We also continue to leverage our leadership position in the industry to advocate for much-needed reform in the sector that will not only level the playing field for all companies, but also support the development and growth of a sustainable industry in the long term |
| Anticipated higher yields should reduce the cost of cultivation in the long run |
| Throughout fiscal 2023, with the dedication of our 1,000 employees across three facilities and our corporate head office, we demonstrated record-breaking international sales for the company, introduced award-winning products, completed extensive efficiency driving CapEx projects and expanded our market share in key growth categories, reaching the number 2 spot among LPs, all while maintaining our negligible debt position |
| So I am very pleased to join this incredibly focused and disciplined team and particularly pleased to join at such a pivotal time in the company's evolution |
| And we continue to be proud of the work we do every day in the domestic market in Canada |
| One of our key domestic areas of focus for fiscal 2024 will be to increase our share of the vapes category, which we believe will unlock market share gains |
| And in keeping with our core strength of innovation, we are pleased that our first-to-market Rip-Strip Hash innovation is performing well in the market and that we have successfully grown the hash category by bringing in new users with this flavorful and easy-to-use format |
| With our three facilities now fully expanded and equipped with substantial automation capabilities, Organigram is poised to more aggressively compete in the ready-to-consume product category as consumers are displaying a clear preference today for convenience and quality |
| The investments we made in our pre-roll processes in fiscal 2023 and the ensuing ramp-up have led to a 38% increase in tube style pre-roll production run rate, a 100% improvement in packaging throughput and 150% improvement in the rate that we produce are SHRED Heavies |
| As Beena mentioned, in comparison to Q4 of fiscal 2024, where adjusted gross margin was 17%, we achieved a marked improvement in adjusted gross margin in Q1 |
| So, we're very excited about the opportunity to increase our shipments, to our partner now in Germany |
| And as we work through the appropriate stability testing and regulatory requirements, we're excited that we finally got our first shipment out into the German market |
| And in December 2023, we had our strongest month ever with $33.5 million in retail sales, driven by consumer receptiveness to innovation in tube style pre-rolls, infused pre-rolls and gummies |
| The reintroduction of JOLTS was a large contributing factor to our success in the quarter as well, with $2.9 million in ship sales in Q1 |
| We are pleased to report that in the quarter, we returned to positive adjusted EBITDA of $136,000 compared to Q4 fiscal 2023's adjusted EBITDA of negative $2.4 million, representing an increase of $2.5 million |
| For us, vapes is a big opportunity for improved mix, because we're competing in the flowers that has fullness of margins |
| Statement |
|---|
| Q1 fiscal 2024 growth and net revenue decreased by 8% and 16%, respectively, primarily due to net decreases in international revenue of $4.8 million and medical sales of $1 million when compared to Q1 fiscal 2023 |
| We harvested approximately 20,000 kilograms of flower during Q1 fiscal 2024 compared to about 22,000 kilograms in Q1 fiscal 2023, which represents a decrease of 11% |
| The increase in net loss from the comparative period is primarily due to a lower gross margin resulting from a reduction in the gain on fair value of biological assets |
| While the company expects to continue to report growth in year-over-year adjusted EBITDA, periods when the company achieved significant increases to sales may result in increases to receivables, which could negatively impact cash from operating activities |
| As capital markets have dried up and increased enforcement removes unfair advantages and penalizes those who don't contribute to the health of our sector, the Canadian market will experience a shakeout |
| Organigram's cost of sales in Q1 fiscal 2024 was $27.3 million compared to $31.6 million in Q1 fiscal 2023, representing a decrease of 14% |
| Companies engaging in THC inflation who have dubiously enjoyed temporary competitive advantages to artificially inflating their labeled THC content are facing more pressure as Health Canada and the OCS have announced random THC testing protocols |
| And the boards are challenging |
| And so yes, Germany might not be as exciting as it was about a year ago, when everybody thought - that was coming |
| So if we're looking at investing in MSOs, SSOs, or even brand plays, we recognize those are more difficult to structure, and those will probably take us a little bit longer |
| And what is new news, and we saw a little bit of this last year where, you know, the CRA went in to a couple of LPs last year, and couldn't see any hope of getting their excise duties repaid, and closed them down |
| The decrease in cost of sales over the same prior year period was primarily due to lower medical and international sales and lower cultivation and post-harvest costs |
| So when outbound of the mix and while vapes has been a competitive market in the past |
| But we expect this is going to somehow start to stop as testing continues |
Please consider a small donation if you think this website provides you with relevant information